The authorities of Kazakhstan and the British-Swedish company AstraZeneca have signed a plan to localize the production of drugs in the republic, Kazakh Invest reported.
This agreement is aimed at fulfilling the instructions of the country's president, Kassim-Jomart Tokaev, to increase the share of domestically produced medicines on the domestic market to 50%. Postiganto is an agreement with AstraZeneca to establish contract manufacturing of original medicines with an investment volume of USD 32 million.
The signing of the document took place within the official visit of British Foreign Minister David Cameron. He met the head of Kazakhstan, as well as his Kazakh counterpart Murat Nurtleu.